In addition, studies with mice expressing a dominant negative TRβ mutant spontaneously develop metastastic thyroid carcinoma [23] and pituitary tumors [24], and increased aggressiveness of skin tumors is found in genetically modified mice lacking TRs [22], further demonstrating the role of these receptors as inhibitors of tumor progression. This evidence concerns the gene THRB and neoplasm.